Vaka 7
Özet
Epidermoid kistler, ektodermal kalıntılardan gelişen, benign ve yavaş büyüyen lezyonlardır. Sıklıkla serebellopontin köşede görülür. MRG’de T1 hipointens, T2 hiperintens olup BOS’a benzer görünse de FLAIR’da heterojen sinyallidir. Difüzyon kısıtlaması tipiktir. Kontrast tutmazlar. Ayırıcı tanıda araknoid kist ve şvannom önemlidir.
Referanslar
Lin EP, Crane BT. The Management and Imaging of Vestibular Schwannomas. American journal of neuroradiology 2017;38(11):2034–2043. https://doi.org/10.3174/ajnr.A5213
Sriskandan N, Connor SE. The role of radiology in the diagnosis and management of vestibular schwannoma. Clinical Radiology. 2011;66(4):357-365. doi: 10.1016/j.crad.2010.10.016. Epub 2011 Jan 20. PMID: 21356397
Mahaley MS Jr, Mettlin C, Natarajan N, et al. Analysis of patterns of care of brain tumor patients in the United States: a study of the Brain Tumor Section of the AANS and the CNS and the Commission on Cancer of the ACS. Clinical Neurosurgery 1990;36:347–352.
Matthies C, Samii M, Krebs S. Management of vestibular schwannomas: radiological features in 202 cases. Neurosurgery 1997;40:469–482.
Yuan L, Lu J, Shu X, et al. The Classification of Vestibular Schwannoma (VS) and Cerebellopontine Angle Meningioma (CPAM) Based on Multimodal Magnetic Resonance Imaging Analysis. Diagnostics (Basel). 2025;15(9):1157. doi: 10.3390/diagnostics15091157. PMID: 40361975; PMCID: PMC12071267
Brovold BL, Lohse CM, Mehta PMet al. Medially Migrating Vestibular Schwannomas: A Review of 10 Cases. Otology & Neurotology. 2025;46(1):e41-e45. doi: 10.1097/MAO.0000000000004381
Sergi B, Settimi S, Federici G, et al. Factors Influencing Personalized Management of Vestibular Schwannoma: A Systematic Review. Journal of Personalized Medicine. 2022;12(10):1616. doi: 10.3390/jpm12101616
Tuleasca C, Kotecha R, Sahgal A, et al. Large vestibular schwannoma treated using a cranial nerve sparing approach with planned subtotal microsurgical resection and stereotactic radiosurgery: meta-analysis and International Stereotactic Radiosurgery Society (ISRS) practice guidelines. Journal of Neuro-oncology. 2025;173(2):245-262. doi: 10.1007/s11060-025-04990-6
